Melanoma

Opdivo anti-PD-1 immunotherapy can be used to treat both stage III and more advanced melanoma.

Treatment of Stage IV Melanoma Cancer

5 year follow up continues to demonstrate Yervoy + Opdivo superiority-better understanding of side effects is emerging.

Genomic testing should be performed in all patients-precision medicines reduce recurrences and prolong survival.

Understanding Melanoma Staging and Clark Levels

BRAF-MEK-Immunotherapy combination improves survival in stage III and advanced melanoma with V600E and V600K mutations.

Cancer Connect - Treatment of Recurrent Melanoma